Region Skane
skane.seTotal trials
367
Active
124
Phase 3
8
Total enrollment
494,639
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 18 of 18 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ropivacain 5 mg/ml + Clonidine | — | — | — | — | 2 | ||
| Shingrix | — | — | — | — | — | 2 | |
| Adenosine | — | — | — | — | — | 1 | |
| Penicillin G_1200mg | — | — | — | — | — | 1 | |
| cloxacillin | — | — | — | — | — | 1 | |
| Collagenase Clostridium Histolyticum | — | — | — | — | — | 1 | |
| vaccination with 2 doses of Shingrix vaccine | — | — | — | — | — | 1 | |
| Afatinib/Dacomitinib | — | — | — | — | — | 1 | |
| Osimertinib | — | — | — | — | — | 1 | |
| L-menthol | — | — | — | — | — | 3 | |
| Aliskiren | — | — | — | — | — | 1 | |
| Enalapril | — | — | — | — | — | 1 | |
| Semaglutide | — | — | — | — | — | 1 | |
| Dapagliflozin | — | — | — | — | — | 1 | |
| Psilocybin | — | — | — | — | — | 1 | |
| STEM-PD | — | — | — | — | — | 1 | |
| Chemotherapy | — | — | — | — | — | 1 | |
| TNF-inhibition | — | — | — | — | — | 1 |
Next readouts
- 2021-12-15
- 2024-09-01
- 2025-03-30
- 2025-12-31
- 2026-10-01
- 2026-12
- 2026-12-31
- 2027-01
- 2027-02
- 2027-03-01
Top conditions
- Breast Cancer9
- Osteoarthritis7
- Suicide, Attempted6
- Stroke6
- Depression6
- Cancer5
- Septic Shock5
- Carpal Tunnel Syndrome5
Frequently asked questions about Region Skane
- How many clinical trials does Region Skane have on ClinicalTrials.gov?
- Region Skane is listed as the lead sponsor on 367 clinical trials in ClinicalTrials.gov, 124 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Region Skane's trials are in Phase 3?
- 8 of Region Skane's trials are in Phase 3, spread across 18 active drug programs.
- What therapeutic areas does Region Skane focus on?
- Region Skane's most-studied conditions on ClinicalTrials.gov are Breast Cancer, Osteoarthritis, Suicide, Attempted, Stroke, Depression.
- When are Region Skane's next clinical trial readouts?
- Region Skane has 10 upcoming primary-completion readouts tracked here; the soonest is “Semaglutide and Dapagliflozin in Diabetic Patients With Different Pathophysiology”, expected around 2021-12-15.